HealthTree University for Multiple Myeloma playlists - Search - BetterTube

Comparing Outcomes in Younger Multiple Myeloma Patients | Marc Braunstein, MD, PhD | #ASH24

Comparing Outcomes in Younger Multiple Myeloma Patients | Marc Braunstein, MD, PhD | #ASH24 HealthTree Foundation

629 views - 1 year ago

Boosting Infection Protection in Myeloma Patients with IvIG Therapy | Betsy O’Donnell, MD | #ASH24

Boosting Infection Protection in Myeloma Patients with IvIG Therapy | Betsy O’Donnell, MD | #ASH24 HealthTree Foundation

761 views - 1 year ago

MRD2STOP: Can multiple myeloma patients stop treatment? | Ben Derman, MD | #ASH24

MRD2STOP: Can multiple myeloma patients stop treatment? | Ben Derman, MD | #ASH24 HealthTree Foundation

2.4K views - 1 year ago

Update on BMS-986393, a GPRC5D #Myeloma CAR-T | Susan Bal, MD | #ASH24

Update on BMS-986393, a GPRC5D #Myeloma CAR-T | Susan Bal, MD | #ASH24 HealthTree Foundation

602 views - 1 year ago

Plasmacytomas are More Genomically Complex than Myeloma in the Bone Marrow | Urvi Shah, MD | #ASH24

Plasmacytomas are More Genomically Complex than Myeloma in the Bone Marrow | Urvi Shah, MD | #ASH24 HealthTree Foundation

576 views - 1 year ago

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t HealthTree Foundation for Multiple Myeloma

804 views - 1 week ago

Demonstrating Better Protection with 3 Flu Shots in Myeloma | Craig Hofmeister, MD, MPH | #ASH24

Demonstrating Better Protection with 3 Flu Shots in Myeloma | Craig Hofmeister, MD, MPH | #ASH24 HealthTree Foundation

183 views - 1 year ago

Building a Myeloma-Specific Score to Predict CAR-T Therapy Toxicities | Utkarsh Goel MD | #ASH24

Building a Myeloma-Specific Score to Predict CAR-T Therapy Toxicities | Utkarsh Goel MD | #ASH24 HealthTree Foundation

353 views - 1 year ago

The Unique Power of Whole Genome Sequencing in Multiple Myeloma | Francesco Maura, MD | #ASH24

The Unique Power of Whole Genome Sequencing in Multiple Myeloma | Francesco Maura, MD | #ASH24 HealthTree Foundation

113 views - 1 year ago

Combination of Selinexor, Pomalidomide, & Dexamethasone for RRMM | Muhamed Baljevic, MD | #ASH24

Combination of Selinexor, Pomalidomide, & Dexamethasone for RRMM | Muhamed Baljevic, MD | #ASH24 HealthTree Foundation

191 views - 1 year ago

Myeloma Patient Experiences with Talquetamab | Jay Hydren, PhD, CSCS | #ASH24

Myeloma Patient Experiences with Talquetamab | Jay Hydren, PhD, CSCS | #ASH24 HealthTree Foundation

309 views - 1 year ago

Late Complications and Long-term Care of CAR T-cell Patients | Michael Bishop | #ASH24

Late Complications and Long-term Care of CAR T-cell Patients | Michael Bishop | #ASH24 HealthTree Foundation

2.1K views - 1 year ago

Belantamab + Standard of Care for Newly Diagnosed Myeloma (DreaMM-9) | Saad Usmani, MD | #ASH24

Belantamab + Standard of Care for Newly Diagnosed Myeloma (DreaMM-9) | Saad Usmani, MD | #ASH24 HealthTree Foundation

292 views - 1 year ago

$Optimizing Modakafusp Alfa for Relapsed/Refractory Multiple Myeloma | Shebli Atrash, MD | #ASH24$ 3:14

Optimizing Modakafusp Alfa for Relapsed/Refractory Multiple Myeloma | Shebli Atrash, MD | #ASH24 HealthTree Foundation

90 views - 1 year ago

IVIG and Preventing Infections in Myeloma Patients on Teclistamab | Heloise Cheruvalath | #ASH24

IVIG and Preventing Infections in Myeloma Patients on Teclistamab | Heloise Cheruvalath | #ASH24 HealthTree Foundation

359 views - 1 year ago

Belentamab Plus Cyclophosphamide & Dexamethasone in RRMM (ProMMise Study) | Rakesh Popat | #ASH24

Belentamab Plus Cyclophosphamide & Dexamethasone in RRMM (ProMMise Study) | Rakesh Popat | #ASH24 HealthTree Foundation

104 views - 1 year ago

Looking Back: Real-World Data on CAR-T and Bispecifics for RRMM | Natalia Neparidze, MD | #ASH24

Looking Back: Real-World Data on CAR-T and Bispecifics for RRMM | Natalia Neparidze, MD | #ASH24 HealthTree Foundation

542 views - 1 year ago

Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24

Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24 HealthTree Foundation

1.6K views - 1 year ago

Iberdomide Combos Post-ASCT in Myeloma: Eliminating Residual Disease (COMMANDER) |Dr. Costa | #ASH24

Iberdomide Combos Post-ASCT in Myeloma: Eliminating Residual Disease (COMMANDER) |Dr. Costa | #ASH24 HealthTree Foundation

510 views - 1 year ago

Is There a Cure for Myeloma? How Long Will I Live? Dr. Sundar Jagannath on Why Cure is Within Reach

Is There a Cure for Myeloma? How Long Will I Live? Dr. Sundar Jagannath on Why Cure is Within Reach HealthTree Foundation for Multiple Myeloma

14.3K views - 7 months ago